Beta-Thalassemia minor and SARS-CoV-2, prevalence, severity, morbidity and mortality: a systematic review study
Lansiaux, E.; Drouin, E.; Bolm, C.
Show abstract
BackgroundSince the first year of the COVID-19 global pandemic, a hypothesis concerning the possible protection/immunity of beta-thalassemia carriers remains in abeyance. MethodsThree databases (Pubmed Central, Scopus and Google Scholar) were screened and checked in order to extract all studies about incidence of confirmed COVID-19 cases OR mortality rate OR severity assessment OR ICU admission among patients with beta-thalassemia minor, were included in this analysis. The language was limited to English. Studies such as case reports, review studies, and studies that did not have complete data for calculating incidences were excluded. Results and discussionThree studies upon 2265 were selected. According to our systematic-review meta-analysis, beta-thalassemia carriers could be less COVID-19 affected than general population [IRR= 0.9250(0.5752;1.4877)], affected by COVID-19 with a worst severity [OR=1.5933(0.4884;5.1981)], less admissible into ICU [IRR=0.3620(0.0025;51.6821)] and more susceptible to die from COVID-19 or one of its consequences [IRR=1.8542(0.7819;4.3970)]. However, all of those results stay insignificant with a bad p-value (respectively 0.7479, 0.4400, 0.6881, 0.1610). Other large case-control or registry studies are needed to confirm these trends.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Investigation of HLA susceptibility alleles and genotypes with hematological disease among Chinese Han population 94%
- Association of ABO blood group with COVID-19 severity, acute phase reactants and mortality 94%
- Use of an automated pyrosequencing technique for confirmation of Sickle Cell Disease 94%
Similar papers in this journal
- Blood transfusion in care of patients with Visceral Leishmaniasis: a review of practices in therapeutic efficacy studies 92%
- The seroprevalence and trends of SARS-CoV-2 in Delhi, India: A repeated population-based seroepidemiological study 88%
- Molecular characterization of carbapenem resistant Klebsiella pneumoniae clinical isolates: Preliminary experience from a tertiary care teaching hospital in the Himalayas 87%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- Impact of COVID-19 pandemic on rare diseases- A case study on thalassaemia patients in Bangladesh 94%
- Knowledge, attitude, and practices towards COVID-19 among the Rohingya refugees in Cox’s Bazar, Bangladesh 87%
- A community based case-control study to determine the risk factors of dengue fever in Bangladesh 86%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.